Article
27 January 2026 - by Brian Anderson, Rebekah Bayram, Andrew Dressler, Marc Guieb, Niharika Tarimela, Jason Mui
Changes in healthcare legislation and drug manufacturer pricing strategies have made the projection of average wholesale price and ingredient cost trends all the more critical.
Article
05 December 2025 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the key highlights from December, including FDA approvals and launches, and industry developments.
Article
20 August 2025 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the key highlights from August, including FDA approvals and launches, and industry developments.
Article
21 May 2025 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the key highlights from May, including FDA approvals and launches, and industry developments.
Article
11 March 2025 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the key pharmacy highlights from March, including FDA approvals and launches, and industry developments.
Article
20 November 2024 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the key pharmacy highlights from November , including FDA approvals and launches, and industry developments.
Article
14 August 2024 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail key pharmacy news from July, including FDA approvals and launches and industry developments.
Article
24 July 2024 - by Brian Anderson, Rebekah Bayram, Andrew Dressler, Marc Guieb, Niharika Tarimela, Jason Mui
Pharmacy benefits costs continue to rise year over year, driven by a variety of factors such as novel treatments, consumer demand, and federal legislation.
Article
17 June 2024 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the latest pharmacy news, including FDA approvals and launches, and industry developments.
Article
20 February 2024 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the latest pharmacy news, trends, and insights, including FDA approvals and launches, clinical trials, and industry developments.